Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
News|Articles|July 16, 2024
Slideshow: Pharmacists Report Burnout is a Major Driver of Understaffing in Pharmacy Times Survey
On a scale from 1 to 10, respondents rated their feelings of burnout an average of 7.25 in the second annual Pharmacy Times Burnout and Mental Health Survey.
Advertisement
Advertisement
Burnout has become a defining challenge in health care—and specifically pharmacy—in recent years. Driven in part by the COVID-19 pandemic, levels of mental health issues have skyrocketed among pharmacists in recent years, as they deal with growing demands and fewer resources.1
Related to this article
VAX-31 met all primary end points against PCV20 and PCV21 in the pivotal phase 3 OPUS-1 trial.
A year after FDA approval in heart failure (HF) with LVEF of 40% or higher, new ACC guidance and trial subanalyses are shaping how pharmacists use finerenone.
The once-nightly drop, previously approved to reverse pupil dilation, met its primary end point in 2 phase 3 trials, with conjunctival hyperemia most common.
Public data may help identify drugs associated with shortages, but hospital inventory and purchasing data could make early-warning tools more useful.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
A summer PCAC vote pushes 6 peptide families toward the 503A bulks list—but the FDA's decision is still pending.
Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
Advertisement
Advertisement